FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310580567> ?p ?o ?g. }

• W4310580567 endingPage "e005457" @default.
• W4310580567 startingPage "e005457" @default.
• W4310580567 abstract "To evaluate the safety and efficacy of selective internal radiation therapy (SIRT) in combination with a PD-1 inhibitor in patients with unresectable hepatocellular carcinoma (uHCC) and liver-only disease ineligible for chemoembolization.NASIR-HCC is a single-arm, multicenter, open-label, phase 2 trial that recruited from 2017 to 2019 patients who were naïve to immunotherapy and had tumors in the BCLC B2 substage (single or multiple tumors beyond the up-to-7 rule), or unilobar tumors with segmental or lobar portal vein invasion (PVI); no extrahepatic spread; and preserved liver function. Patients received SIRT followed 3 weeks later by nivolumab (240 mg every 2 weeks) for up to 24 doses or until disease progression or unacceptable toxicity. Safety was the primary endpoint. Secondary objectives included objective response rate (ORR), time to progression (TTP), and overall survival (OS).42 patients received SIRT (31 BCLC-B2, 11 with PVI) and were followed for a median of 22.2 months. 27 patients discontinued and 1 never received Nivolumab. 41 patients had any-grade adverse events (AE) and 21 had serious AEs (SAE). Treatment-related AEs and SAEs grade 3-4 occurred in 8 and 5 patients, respectively. Using RECIST 1.1 criteria, ORR reported by investigators was 41.5% (95% CI 26.3% to 57.9%). Four patients were downstaged to partial hepatectomy. Median TTP was 8.8 months (95% CI 7.0 to 10.5) and median OS was 20.9 months (95% CI 17.7 to 24.1).The combination of SIRT and nivolumab has shown an acceptable safety profile and signs of antitumor activity in the treatment of patients with uHCC that were fit for SIRT.NCT03380130." @default.
• W4310580567 created "2022-12-12" @default.
• W4310580567 creator A5007350603 @default.
• W4310580567 creator A5021372111 @default.
• W4310580567 creator A5021536315 @default.
• W4310580567 creator A5023733918 @default.
• W4310580567 creator A5028235105 @default.
• W4310580567 creator A5034327827 @default.
• W4310580567 creator A5041489126 @default.
• W4310580567 creator A5043869708 @default.
• W4310580567 creator A5059305400 @default.
• W4310580567 creator A5065992876 @default.
• W4310580567 creator A5066116117 @default.
• W4310580567 creator A5074084744 @default.
• W4310580567 creator A5080639399 @default.
• W4310580567 creator A5081163611 @default.
• W4310580567 creator A5081603193 @default.
• W4310580567 creator A5085766415 @default.
• W4310580567 date "2022-11-01" @default.
• W4310580567 modified "2023-10-18" @default.
• W4310580567 title "Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study" @default.
• W4310580567 cites W1971380142 @default.
• W4310580567 cites W1973076899 @default.
• W4310580567 cites W1984101482 @default.
• W4310580567 cites W2019607817 @default.
• W4310580567 cites W2037501213 @default.
• W4310580567 cites W2066593706 @default.
• W4310580567 cites W2103742396 @default.
• W4310580567 cites W2141444851 @default.
• W4310580567 cites W2186902482 @default.
• W4310580567 cites W2606367731 @default.
• W4310580567 cites W2765356289 @default.
• W4310580567 cites W2772445760 @default.
• W4310580567 cites W2787039411 @default.
• W4310580567 cites W2791703762 @default.
• W4310580567 cites W2889970471 @default.
• W4310580567 cites W2968989098 @default.
• W4310580567 cites W2977722669 @default.
• W4310580567 cites W3010976936 @default.
• W4310580567 cites W3025022288 @default.
• W4310580567 cites W3040084298 @default.
• W4310580567 cites W3041197920 @default.
• W4310580567 cites W3082827286 @default.
• W4310580567 cites W3096906134 @default.
• W4310580567 cites W3110482332 @default.
• W4310580567 cites W3128646645 @default.
• W4310580567 cites W3152534107 @default.
• W4310580567 cites W3180754516 @default.
• W4310580567 cites W3208952443 @default.
• W4310580567 cites W3213277274 @default.
• W4310580567 cites W4205565447 @default.
• W4310580567 cites W4206898533 @default.
• W4310580567 cites W4242769447 @default.
• W4310580567 doi "https://doi.org/10.1136/jitc-2022-005457" @default.
• W4310580567 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36450386" @default.
• W4310580567 hasPublicationYear "2022" @default.
• W4310580567 type Work @default.
• W4310580567 citedByCount "12" @default.
• W4310580567 countsByYear W43105805672023 @default.
• W4310580567 crossrefType "journal-article" @default.
• W4310580567 hasAuthorship W4310580567A5007350603 @default.
• W4310580567 hasAuthorship W4310580567A5021372111 @default.
• W4310580567 hasAuthorship W4310580567A5021536315 @default.
• W4310580567 hasAuthorship W4310580567A5023733918 @default.
• W4310580567 hasAuthorship W4310580567A5028235105 @default.
• W4310580567 hasAuthorship W4310580567A5034327827 @default.
• W4310580567 hasAuthorship W4310580567A5041489126 @default.
• W4310580567 hasAuthorship W4310580567A5043869708 @default.
• W4310580567 hasAuthorship W4310580567A5059305400 @default.
• W4310580567 hasAuthorship W4310580567A5065992876 @default.
• W4310580567 hasAuthorship W4310580567A5066116117 @default.
• W4310580567 hasAuthorship W4310580567A5074084744 @default.
• W4310580567 hasAuthorship W4310580567A5080639399 @default.
• W4310580567 hasAuthorship W4310580567A5081163611 @default.
• W4310580567 hasAuthorship W4310580567A5081603193 @default.
• W4310580567 hasAuthorship W4310580567A5085766415 @default.
• W4310580567 hasBestOaLocation W43105805671 @default.
• W4310580567 hasConcept C121608353 @default.
• W4310580567 hasConcept C126322002 @default.
• W4310580567 hasConcept C141071460 @default.
• W4310580567 hasConcept C143998085 @default.
• W4310580567 hasConcept C197934379 @default.
• W4310580567 hasConcept C203092338 @default.
• W4310580567 hasConcept C2777701055 @default.
• W4310580567 hasConcept C2778019345 @default.
• W4310580567 hasConcept C2779185275 @default.
• W4310580567 hasConcept C2780030458 @default.
• W4310580567 hasConcept C29730261 @default.
• W4310580567 hasConcept C2992208098 @default.
• W4310580567 hasConcept C31760486 @default.
• W4310580567 hasConcept C535046627 @default.
• W4310580567 hasConcept C71924100 @default.
• W4310580567 hasConcept C90924648 @default.
• W4310580567 hasConceptScore W4310580567C121608353 @default.
• W4310580567 hasConceptScore W4310580567C126322002 @default.
• W4310580567 hasConceptScore W4310580567C141071460 @default.
• W4310580567 hasConceptScore W4310580567C143998085 @default.
• W4310580567 hasConceptScore W4310580567C197934379 @default.

• next